|
|
|
Consensus Conference Topics
(established in Advisory Board Meeting, 2-28-00):
- Incorporating uncertainty into the design of clinical research -
preclinical phase, phase I, phase II, and phase III
- Using surrogate endpoints in clinical research
- How to use adaptive methods to improve the efficiency of
phase II/III trials
- Determining whether and when to enter phase III of a clinical trial
- Standardizing the summary and reporting of phase III safety data
- Standardizing the purity of data for submission
- The role of decision analysis in drug development
- Post-approval development in clinical trials / phase IV
- Sequential dose-finding strategies
- Monitoring ongoing trials (predictive probabilities, etc.)
- Study selection in the setting of limited patient resources and
global priorities / Which study to run?
- Using hybrid phase transitions / Whither phases I, II, and III?
For questions concerning these pages, contact the
Department of
Biostatistics Webmaster.
|
|
